
NASDAQHealthcareMedical - Devices
أحدث البيانات المتاحة
14.21 US$
+0.13 US$ · +0.92%
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
الإغلاق السابق
14.21 US$
+0.13 US$ · +0.92%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
نطاق اليوم
السعر الحالي 14.21 US$
نطاق 52 أسبوعًا
السعر الحالي 14.21 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
85
قيمة جذابة جدًا
المشاعر
64
صعودي
المخاطر
41
مخاطر أعلى من المعتاد
الزخم
52
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
نطاق اليوم
السعر الحالي 14.21 US$
نطاق 52 أسبوعًا
السعر الحالي 14.21 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 370.5 مليون USD | 394.82 مليون USD | 492.05 مليون USD | 454.27 مليون USD | 357.57 مليون USD |
| تكلفة البضاعة المباعة | 79.53 مليون USD | 77.75 مليون USD | 80.71 مليون USD | 73.49 مليون USD | 53.59 مليون USD |
| الربح الإجمالي | 290.97 مليون USD | 317.07 مليون USD | 411.34 مليون USD | 380.79 مليون USD | 303.97 مليون USD |
| البحث والتطوير | 13.32 مليون USD | 13.14 مليون USD | 13.41 مليون USD | 12.43 مليون USD | 9.53 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 192.26 مليون USD | 191.4 مليون USD | 202.27 مليون USD | 170.51 مليون USD | 127.76 مليون USD |
| نفقات التشغيل | 205.58 مليون USD | 204.54 مليون USD | 215.68 مليون USD | 182.93 مليون USD | 136.5 مليون USD |
| دخل الفوائد | 24.94 مليون USD | 30.94 مليون USD | 21.61 مليون USD | 3.61 مليون USD | 525 ألف USD |
| الاستهلاك والإطفاء | 695 ألف USD | 728 ألف USD | 623 ألف USD | 680 ألف USD | 517 ألف USD |
| الدخل التشغيلي | 85.39 مليون USD | 112.53 مليون USD | 195.66 مليون USD | 197.85 مليون USD | 167.48 مليون USD |
| صافي الدخل | 93.83 مليون USD | 181.28 مليون USD | 197.92 مليون USD | 161.52 مليون USD | 164.97 مليون USD |
تم تحديث حقائق الشركة 10 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
iShares Core MSCI EAFE ETFIEFA7.84 مليون0.00%188.12 مليار USD0.07%96.52 US$+0.68%
iShares MSCI EAFE Small-Cap ETFSCZ2.42 مليون0.02%12.71 مليار USD0.40%83.93 US$+0.82%
iShares Core MSCI Total International Stock ETFIXUS2.18 مليون0.00%58.21 مليار USD0.07%94.99 US$+0.90%
ARK Israel Innovative Technology ETFIZRL1.96 مليون1.50%136.9 مليون USD0.49%28.36 US$+1.61%
Avantis International Small Cap Value ETFAVDV1.48 مليون0.01%20.04 مليار USD0.36%108.52 US$+0.74%
iShares MSCI Israel ETFEIS1.43 مليون0.17%856.81 مليون USD0.59%118.28 US$+0.54%
Schwab Fundamental International Small Company Index ETFFNDC1.41 مليون0.05%3.05 مليار USD0.39%49.73 US$+0.73%
iShares Core MSCI International Developed Markets ETFIDEV1.4 مليون0.00%32.64 مليار USD0.04%89.21 US$+0.73%
iShares Core MSCI EAFE ETFIEFA
iShares MSCI EAFE Small-Cap ETFSCZ
iShares Core MSCI Total International Stock ETFIXUS
ARK Israel Innovative Technology ETFIZRL
Avantis International Small Cap Value ETFAVDV
iShares MSCI Israel ETFEIS
Schwab Fundamental International Small Company Index ETFFNDC
iShares Core MSCI International Developed Markets ETFIDEVالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.